THE DIAGNOSTIC AND CLINICAL VALUE OF DETERMINATION OF α1-ANTITRYPSIN PHENOTYPE IN SYSTEMIC VASCULITIDES

α1-Antitrypsin (α1-AT) deficiency is a common genetic disorder characterized by low serum α1-AT levels and a clinical manifestation of pulmonary emphysema and liver disease. In addition to its classical manifestations, α1-AT deficiency frequently accompanies granulomatosis with polyangiitis (GPA); in this case the role of α1-AT deficiency in the clinical course of GPA has not been defined. Objective: to estimate the prevalence of pathological α1-AT phenotypes in GPA and other systemic vasculitides (SV) and to determinate their impact on the clinical course of GPA. Subjects and methods. The investigation enrolled 86 patients with SV, including GPA (n=47), microscopic polyangiitis (MPA) (n=16), eosinophilic granulomatosis with polyangiitis (EGPA) (n=12), and polyarteritis nodosa (PAN) (n=11). A control group included 46 healthy donors. Isoelectric focusing was used to phenotype α1-AT in blood samples and its concentrations were determined. The phenotypes of α1-AT were compared with the overall SV activity index using the Birmingham Vasculitis Activity Score (BVAS), the vasculitis damage index (VDI), the nature of an organ lesion, and the markers of immune inflammation (proteinase 3-antineutrophil cytoplasmic antibodies, total IgG, and C3 and C4 fractions of the complement system). Results and discussion. Pathological α1-AT phenotypes were detected in 17% (8/47) of the patients with GPA, 6.25% (1/16) of those with MPA and absent in EGPA and PAN. Patients with GPA had PiZZ (n=1), PiMZ (n=4), PiMF (n=2), and PiMS (n=1) phenotypes; those with MPA had a PiMS-phenotype. The detection of a pathological α1-AT phenotype in patients with GPA was characterized by the high values of BVAS and VDI (p<0.05) and the elevated levels of serum creatinine (p><0.01), anti-proteinase 3 antibodies, IgG, C3 and C4 fractions of the complement system (p><0.05). Conclusion. Pathological α1-AT phenotypes are more frequently detected in patients with GPA, which is accompanied by an enhanced immunological activity of the disease and high activity and damage indices. Key words: α1-antitrypsin; α1-antitrypsin deficiency; phenotyping; granulomatosis with polyangiitis; systemic vasculitis.><0.05) and the elevated levels of serum creatinine (p<0.01), anti-proteinase 3 antibodies, IgG, C3 and C4 fractions of the complement system (p<0.05). Conclusion. Pathological α1-AT phenotypes are more frequently detected in patients with GPA, which is accompanied by an enhanced immunological activity of the disease and high activity and damage indices.

1. Шевченко ОП. Белки острой фазы воспаления. Лаборатория. 1996;(1):10-7 [Shevchenko OP. Proteins of the acute phase of inflammation. Laboratoriya. 1996;(1):10-7 (In Russ.)].

2. Greene DN, Elliott-Jelf MC, Straseski JA, Grenache DG. Facilitating the laboratory diagnosis of alpha1-antitrypsin deficiency. Am J Clin Pathol. 2013;139(2):184-91. doi: 10.1309/AJCP6XBK8ULZXWFP

3. Первакова МЮ, Эмануэль ВЛ, Суркова ЕА и др. Сопоставление методов электрофореза, иммунотурбидиметрического измерения и фенотипирования альфа-1-антитрипсина для диагностики альфа-1-антитрипсиновой недостаточности. Клиническая лабораторная диагностика. 2015;60(10):28-32 [Pervakova MYu, Emanuel VL, Surkova EA, et al. The comparison of techniques of electrophoresis, immune turbidynamic measurement and phenotyping of alpha-1-antitrypsin for diagnostic of alpha-1-antitrypsin insufficiency. Klinicheskaya Laboratornaya Diagnostika. 2015;60(10):28-32 (In Russ.)].

4. Fregonese L, Stolk J. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis. 2008;3:16. doi: 10.1186/1750-1172-3-16

5. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168(7):818-900. doi: 10.1164/rccm.168.7.818

6. Pervakova MY, Emanuel VL, Titova ON, et al. The diagnostic value of alpha-1-antitrypsin phenotype in patients with granulomatosis with polyangiitis. Int J Rheumatol. 2016;2016:7831410. doi: 10.1155/2016/7831410

7. Griffith ME, Lovegrove JU, Gaskin G, et al. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrol Dial Transplant. 1996;11(3):438-43. doi: 10.1093/ndt/11.3.438

8. De Serres F, Blanco I. Role of alpha-1 antitrypsin in human health and disease. J Intern Med. 2014;276(4):311-35. doi: 10.1111/joim.12239

9. Suzuki K. Neutrophil functions of patients with vasculitis related to myeloperoxidase-specific anti-neutrophil antibody. Int J Hematol. 2001;74(2):134-43. doi: 10.1007/BF02981995

10. Bergin DA, Reeves EP, Hurley K, et al. The circulating proteinase inhibitor alpha-1 antitrypsin regulates neutrophil degranulation and autoimmunity. Sci Transl Med. 2014;6(217):217ra1. doi: 10.1126/scitranslmed.3007116

11. Mohammad A, Segelmark M. Primary systemic vasculitis with severe alpha1-antitrypsin deficiency revisited. Scand J Rheumatol. 2014;43(3):242-5. doi: 10.3109/03009742.2013.846405

12. Subramanian S, Shahaf G, Ozeri E. Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice. Metab Brain Dis. 2011;26(2):107-13. doi: 10.1007/s11011-011- 9239-9

13. Pott GB, Chan ED, Dinarello CA, Shapiro L. Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J Leukoc Biol. 2009;85(5):886-95. doi: 10.1189/jlb.0208145

14. Мазуров ВИ, Беляева ИБ, редакторы. Диффузные болезни соединительной ткани. Руководство для врачей. Санкт- Петербург: Спецлит; 2009. C. 41-60 [Mazurov VI, Belyaeva IB, editors. Diffuznye bolezni soedinitel'noi tkani. Rukovodstvo dlya vrachei [Diffuse diseases of connective tissue. Guidelines for doctors]. Sankt-Peterburg: Spetslit; 2009. P. 41-60].

15. Лапин СВ, Мазинг АВ, Булгакова ТВ и др. Выявление антинуклеарных антител: международные рекомендации и собственный опыт. Современная лаборатория. 2014;3(15):40-5 [Lapin SV, Mazing AV, Bulgakova TV, et al. Identification of antinuclear antibodies: international recommendations and own experience. Sovremennaya Laboratoriya. 2014;3(15):40-5 (In Russ.)].

16. Taekema-Roelvink ME, Kooten C, Kooij SV, et al. Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1. J Am Soc Nephrol. 2001;12(5):932-40.

17. Grimminger F, Hattar K, Papavassilis C, et al. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation. J Exp Med. 1996;184(4):1567-72. doi: 10.1084/jem.184.4.1567

18. Van de Wiel BA, Dolman KM, van der Meer-Gerritsen CH, et al. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity. Clin Exp Immunol. 1992;90(3):409-14. doi: 10.1111/j.1365-2249.1992.tb05860.x

19. Hernandez Perez JM, Fumero Garcia S, Alvarez Pio A. Successful alpha1-antitrypsin replacement therapy in a patient with alpha1- antitrypsin deficiency and granulomatosis with polyangiitis. Rheumatology (Oxford). 2013;52(4):755-7. doi: 10.1093/rheumatology/kes233

20. Sandford AJ, Weir TD, Spinelli JJ, Pare PD. Z and S mutations of the alpha1-antitrypsin gene and the risk of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 1999;20(2):287-91. doi: 10.1165/ajrcmb.20.2.3177